New CMS Medicare Advantage Rule Could Uncover Billions in Overpayments by 2018 Audits

New CMS Medicare Advantage Rule Could Uncover Billions in Overpayments by 2018 Audits



In a significant development for the healthcare finance sector, the Centers for Medicare & Medicaid Services (CMS) has put forth a groundbreaking proposed rule titled Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). Released on November 16, 2026, this rule aims to combat fraud, waste, and abuse in programs like Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP). The proposal has garnered considerable attention, particularly regarding its implications for Medicare Advantage plans that could lead to the recovery of substantial overpayments.

Potential Impact of the Proposed Changes



One of the most striking components of the proposal is its focus on Medicare Advantage risk adjustment data validation (RADV) audits. According to initial reports, CMS plans to extrapolate findings from a sample of enrollees, affecting an entire Medicare Advantage contract, with the audits dating back to the payment year 2018. This method could facilitate recovery of an estimated $9 billion in overpayments for each payment year.

The ripple effects of this proposed rule are already being felt in the managed care market. On November 18, the day after the announcement, stocks of major healthcare companies experienced notable declines. Shares for UnitedHealth Group dwindled by 10.21% to $349.91, Humana saw a drop of 12.98% to $385.78, while CVS Health fell 5.2% to $81.35.

Recent Financial Performances of Major Players



As stakeholders in the healthcare market watch these developments closely, let’s examine the current financial updates from some major companies involved in managed care services.

1. UnitedHealth Group Incorporated (NYSE UNH) reported revenues of $112.7 billion for Q3 2026, showcasing earnings from operations of $6.6 billion. It raised its forecast for adjusted net earnings to at least $20.50 per share, despite the market's reaction to regulatory uncertainty.

2. Humana Inc. (NYSE HUM) announced the upcoming launch of a national Gold Card program, aimed at expediting access to MRI, CT, and MRA imaging through a waiver of prior authorization for eligible providers.

3. CVS Health Corporation (NYSE CVS) officially recorded Q3 revenues of $108.4 billion, marking a 5.4% increase compared to the same period last year. The company raised its Adjusted EPS guidance for the full year to no less than $8.20.

4. Elevance Health, Inc. (NYSE ELV) noted third-quarter revenue of $50.4 billion and increased its diluted EPS guidance to at least $22.00 for the year. The company has reported a slight revenue increase from the previous year's third quarter.

5. Lastly, Molina Healthcare, Inc. (NYSE MOH) disclosed premium revenue of approximately $10.5 billion, and it firmly reaffirmed guidance for approximately $42 billion in premium revenue for 2026.

The Path Ahead



With public comments on the proposed rule open until January 19, 2027, stakeholders including insurers, investors, and financial analysts will be keenly observing the feedback and subsequent adjustments to this vital measure. The future of managed care could hinge on how effectively CMS implements these audits and how healthcare companies adjust to the impending changes. Investors are advised to remain diligent and consult their financial advisors as the landscape evolves following the potential enactment of this rule.

As discussions surrounding healthcare financing continue, the proposal’s acceptance will serve as a critical juncture for not just the Medicare Advantage market, but for the broader healthcare ecosystem.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.